(Q37206372)

18 August 2017

A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma (English)

1 reference

18 August 2017

1 reference

1 reference

Dominic E Sanford

1

1 reference

18 August 2017

Matthew R Porembka

2

1 reference

18 August 2017

Roheena Z Panni

3

1 reference

18 August 2017

Jonathan B Mitchem

4

1 reference

18 August 2017

Brian A Belt

5

1 reference

18 August 2017

Stacey M Plambeck-Suess

6

1 reference

18 August 2017

Goldie Lin

7

1 reference

18 August 2017

David G Denardo

8

1 reference

18 August 2017

Ryan C Fields

9

1 reference

18 August 2017

William G Hawkins

10

1 reference

18 August 2017

Steven M Strasberg

11

1 reference

18 August 2017

A Craig Lockhart

12

1 reference

18 August 2017

Andrea Wang-Gillam

13

1 reference

18 August 2017

Simon Peter Goedegebuure

14

1 reference

18 August 2017

David C Linehan

15

1 reference

18 August 2017

1 May 2013

1 reference

Journal of cancer therapy

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

3

1 reference

18 August 2017

797-803

1 reference

Creative Commons Attribution 4.0 International

18 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Postresection chemotherapy for pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

6 September 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Myeloid-derived suppressor cells as regulators of the immune system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Equilibrium between host and cancer caused by effector T cells killing tumor stroma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Breast-cancer adjuvant therapy with zoledronic acid

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3786568

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24089656

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24089656

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Results of Total Pancreatectomy for Adenocarcinoma of the Pancreas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24089656

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4236/JCT.2013.43096

1 reference

18 August 2017

1 reference

18 August 2017

1 reference